CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED

China Resources Pharmaceutical Group Limited

3320

HK0000311099

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 04:08:17 2024-05-17 am EDT			5-day change	1st Jan Change
6.19 ^HKD	0.00%		+10.93%	+20.66%

May. 16	China Resources Sanjiu, China Resources Power to Continue Cooperating on New Energy Projects	MT
Apr. 24	China Resources Pharmaceutical Group Limited Announces Change of Company Secretary	CI

China Resources Pharmaceutical Group Limited Announces the Resignation of FU Yuning as Chairman of the Board, Non-Executive Director and Chairman of the Nomination Committee

March 27, 2019 at 05:40 am EDT

China Resources Pharmaceutical Group Limited announced that Mr. FU Yuning has resigned as the chairman of the Board, non-executive Director and chairman of the nomination committee of the company, with effect from 21 March 2019, due to his other work arrangement.

Latest news about China Resources Pharmaceutical Group Limited

China Resources Sanjiu, China Resources Power to Continue Cooperating on New Energy Projects	May. 16	MT
China Resources Pharmaceutical Group Limited Announces Change of Company Secretary	Apr. 24	CI
China Resources Pharma Unit Issues 3 Billion Yuan Bonds	Apr. 18	MT
China Resources Dong-E-E-Jiao Company Limited Provides Earnings Guidance for the Three Months Ended 31 March 2024	Apr. 11	CI
China Resources Pharmaceutical Posts Gains in Full Year 2023 Profit	Mar. 26	MT
China Resources Pharmaceutical Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 19 July 2024	Mar. 26	CI
China Resources Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26	CI
CR Boya Bio-Pharmaceutical's 2023 Profit Falls on Lower Revenue	Mar. 14	MT
Nomura Adjusts CR Pharmaceutical Group’s Price Target to HK$8.80 From HK$9.08, Keeps at Buy	Mar. 11	MT
CR Sanjiu Expects Increase in 2023 Profit	Jan. 24	MT
China Resources Pharmaceutical Unit Completes Capital Increase; Shares Fall 3%	Jan. 08	MT
China Resources Pharmaceutical Unit Enters Share Subscription Deals to Boost Capital	Dec. 28	MT
China Resources Pharmaceutical Group Limited Announces Management Changes, Effective on 27 December 2023	Dec. 27	CI
China Resources Pharma Unit Boosts Stake in Jiangzhong Pharma Parent	Dec. 27	MT
China Resources Pharmaceutical Subsidiary Begins Bidding for Potential Share Issuance	Nov. 27	MT
China Resources Pharmaceutical Group Subsidiary Records Rise in Nine-Month Attributable Profit	Nov. 01	MT
Dong-E-E-Jiao's Nine-Moth Profit Rises on Higher Revenue	23-10-31	MT
CR Boya Bio-Pharmaceutical's January-September Profit Increases	23-10-25	MT
Dong-E-E-Jiao Expects January-September Attributable Profit to Rise Up to 60%	23-10-10	MT
China Resources Pharma's Profit Marginally Rises in H1	23-08-31	MT
China Resources Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
CR Sanjiu Medical & Pharmaceutical's H1 Attributable Profit Rises 31%	23-08-29	MT
KPC Pharmaceuticals' Attributable Profit Rises 3.1%; Shares Slip 4%	23-08-29	MT
China Resources Pharmaceutical's Subsidiaries Log Increases in H1 Profits	23-08-25	MT
China Resources Boya's H1 Attributable Profit Jumps 16.9%	23-08-22	MT

Chart China Resources Pharmaceutical Group Limited

Duration

Period

Chart China Resources Pharmaceutical Group Limited

More charts

Company Profile

CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally engaged in the research and development, manufacturing, distribution and retail of pharmaceutical and other healthcare products. The Company mainly operates through three segments. Pharmaceutical Manufacturing segment is engaged in the research and development, manufacturing and sale of pharmaceutical and other healthcare products. Pharmaceutical Distribution segment is engaged in the provision of distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and retail pharmacies. Pharmaceutical Retail segment is involved in the operation of retail pharmacies in China and Hongkong.

Sector

Pharmaceuticals

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for China Resources Pharmaceutical Group Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6.19 HKD

Average target price

7.382 HKD

Spread / Average Target

+19.26%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED	+20.66%	4.98B
ELI LILLY AND COMPANY	+32.14%	694B
NOVO NORDISK A/S	+29.39%	593B
JOHNSON & JOHNSON	-1.56%	371B
MERCK & CO., INC.	+20.01%	331B
ABBVIE INC.	+7.22%	290B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	209B
NOVARTIS AG	+10.02%	209B
AMGEN INC.	+8.61%	169B

Other Pharmaceuticals